跳至主要内容
临床试验/NCT04064008
NCT04064008Enrolling By Invitation不适用

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Z Revision Femoral Stems

MicroPort Orthopedics Inc.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
30
试验地点
1
主要终点
Survivorship of ProFemur Z Stem out to 10 years

研究概览

简要总结

Single center, prospective follow-up of previously implanted subjects

详细描述

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Z Revision Femoral Stems

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Has undergone a revision for nonunion and/or hardware removal (i.e. all conditions resulting in poor quality proximal bone).
  • Subject is implanted with the PROFEMUR® Z Revision Femoral Stem at the time of their revision THA.
  • Subject is willing and able to complete required study visits or assessments.
  • Plans to be available through the 10 year postoperative follow-up visit.
  • Previously implanted bilateral subjects can have both THAs enrolled in the study provided:
  • the PROFEMUR Z Revision Femoral Stem was implanted in both,
  • all other aspects of the Inclusion/Exclusion Criteria are satisfied,
  • enrollment does not exceed the subject count specified in the Clinical Trial Agreement, and
  • the subject agrees to a second Informed Consent document specific to the second THA. Prospective enrollment of a previously unimplanted hip is not permitted in this study.

排除标准

  • Subjects currently enrolled in another clinical study which could affect the endpoints of this protocol.
  • Subject has a PROFEMUR Neck Varus/Valgus CoCr 8 Degree, Part number PHAC 1254 implanted in the enrolled THA.
  • Has or had an overt infection at the time of implantation.
  • Has or had a distant foci of infections (which may cause hematogenous spread to the implant site) at the time of implantation.
  • Has or had a rapid disease progression as manifested by joint destruction or bone absorption apparent on roentgenogram at the time of implantation.
  • Has or had inadequate neuromuscular status (e.g., prior paralysis, fusion, and/or inadequate abductor strength), poor bone stock, poor skin coverage around the joint which would make the procedure unjustifiable.
  • Subjects unwilling to sign the Informed Consent document.
  • Subjects with substance abuse issues.
  • Subjects with an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study.
  • Subjects who are incarcerated or have pending incarceration.

结局指标

主要结局

Survivorship of ProFemur Z Stem out to 10 years

时间窗: 10 years.

Kaplan-Meier survivorship at specific intervals out to 10 years follow up

次要结局

  • to characterize total functional scores for subjects, as assessed by Oxford Hip Scores(2-5 years, 5-7 years, and 10 years.)
  • Revision rate of the Profemur Z stem out to 10 years(2-5 years, 5-7 years, and 10 years.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验